The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures: A HOPE Substudy
Open accessAbstract
In the HOPE-trial, the ACE inhibitor ramipril significantly reduced cardiovascular morbidity and mortality in patients at high risk for cardiovascular events. The benefit could only partly be attributed to the modest mean reduction of office blood pressure (OBP) during the study period (3/2 mm Hg). However, because according to the HOPE protocol ramipril was given once daily at bedtime and blood pressure was measured during the day, the 24-hour reduction of blood pressure may be underestimated based on OBP. Thirty-eight patients with peripheral arterial disease enrolled in the HOPE study underwent 24-hour ambulatory blood pressure (ABP) measurement before randomization and after 1 year. OBP was measured in the sitting position immediately before fitting the ABP measuring equipment to the patients. Ramipril did not significantly reduce OBP (8/2 mm Hg, P =NS) or day ABP (6/2 mm Hg, P =NS) after 1 year. Twenty-four–hour ABP was significantly reduced (10/4 mm Hg, P =0.03), mainly because of a more pronounced blood pressure lowering effect during nighttime (17/8 mm Hg, P <0.001). The night/day ratio was also significantly lowered in the ramipril group. ABP shows greater falls, especially at night, than OBP during treatment with ramipril given once daily at bedtime. Although, OBP is the correct comparator when comparing with previous large intervention trials and epidemiological studies, the effects on cardiovascular morbidity and mortality seen with ramipril in the HOPE study may, to a larger extent than previously ascribed, relate to effects on blood pressure patterns over the 24-hour period.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Blood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.
Verdecchia, P., Porcellati, C., Schillaci, G., Borgioni, C., Ciucci, A., Battistelli, M., Guerrieri, M., Gatteschi, C., Zampi, I., Santucci, A., et al. (1994) · Hypertension · doi:10.1161/01.hyp.24.6.793 · Cited by 1,676
Staessen, J. A. (1999) · JAMA · doi:10.1001/jama.282.6.539 · Cited by 1,592
Prognostic Value of Ambulatory Blood Pressure: Current Evidence and Clinical Implications
Verdecchia, P. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.844 · Cited by 621
Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
Lonn, E. M., Yusuf, S., Jha, P., Montague, T. J., Teo, K. K., Benedict, C. R., & Pitt, B. (1994) · Circulation · doi:10.1161/01.cir.90.4.2056 · Cited by 503
Self-citationCircadian variation and triggering of acute coronary events
Muller, J. E. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70390-x · Cited by 168
Mindlen, F., Nordaby, R. A., Ruiz, M. I. S., Nava-Zavala, A. H., Guzmán, L., Martínez, F., Díaz, R., Mackey, C., Marino, M., Romero, G. S., et al. (1996) · PubMed · Cited by 160
Ambulatory blood pressure monitoring: which arm?
O’Shea, J., & Murphy, M. B. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000998 · Cited by 127
Nocturnal Blood Pressure and Silent Cerebrovascular Lesions in Elderly Japanese
Watanabe, N., Imai, Y., Nagai, K., Tsuji, I., Satoh, H., Sakuma, M., Sakuma, H., Kato, J., Onodera-Kikuchi, N., Yamada, M., et al. (1996) · Stroke · doi:10.1161/01.str.27.8.1319 · Cited by 124
Overview of the angiotensin-converting-enzyme inhibitors
Piepho, R. W. (2000) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/57.suppl_1.s3 · Cited by 118
Through/Peak Ratios of Once Daily Angiotensin Converting Enzyme Inhibitors and Calcium Antagonists
Zannad, F. M., Matzinger, A., & Larché, J. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00021-0 · Cited by 79
Owens, P., & O'Brien, E. T. (1999) · Heart · doi:10.1136/hrt.82.4.477 · Cited by 73
Circadian Variation and Cardiovascular Disease
Muller, J. E., & Tofler, G. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110033251410 · Cited by 72
McCarron, D. A. (1991) · Clinical Cardiology · doi:10.1002/clc.4960140908 · Cited by 17
Heber, M. E., Brigden, G. S., Caruana, M., Lahiri, A., & Raftery, E. B. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90219-6 · Cited by 14
Cited by
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Ambulatory Blood-Pressure Monitoring
Pickering, T. G., Shimbo, D., & Haas, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra060433 · Cited by 778
Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L., Kaplan, N. M., O’Connor, C. M., O’Gara, P. T., & Oparil, S. (2007) · Circulation · doi:10.1161/circulationaha.107.183885 · Cited by 757
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
Crowley, S. D., Gurley, S. B., Herrera, M. J., Ruiz, P., Griffiths, R., Kumar, A. P., Kim, H.-S., Smithies, O., Le, T. H., & Coffman, T. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605545103 · Cited by 714
Metadata
- Authors
- Svensson, P., de Faire, U., Sleight, P., Yusuf, S., & Östergren, J.
- Venue
- Hypertension
- Published
- 2001-12
- Volume
- 38
- Issue
- 6
- Pages
- E28-32
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2117939109
- Cited by
- 491
- References
- 17
- FWCI
- 29.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.